Ventilator Settings on Patients With Acute Brain Injury

Sponsor
University Hospital of North Norway (Other)
Overall Status
Completed
CT.gov ID
NCT03278769
Collaborator
Cambridge University Hospitals NHS Foundation Trust (Other), Hôpital de la Croix-Rousse (Other)
27
1
1
31
0.9

Study Details

Study Description

Brief Summary

The present study is an explorative analysis of the relationship between cerebral blood perfusion and oxygenation and lung mechanical variables at different ventilator settings. It is a safety study excluding patients with severe lung injury or brain edema.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Lung protective ventilator settings
N/A

Detailed Description

The primary goal is to carry out baseline measurements to enable conclusions concerning the safety of lung protective ventilator settings before extending the study to patients with more severe brain and/or lung injury in the future.

The primary objective is to investigate if lung protective ventilator settings (higher Positive end-expiratory pressure and lower tidal volume) as compared with conventional settings.

  1. increase intracranial pressure

  2. diminish cerebral vasoreactive autoregulation as assessed by pressure reactivity index, ie pressure reactivity index will turn positive, which means that it will change the state from intact to impaired autoregulation.

The secondary objective is an exploratory analysis of the relationship between ventilator settings and other well defined respiratory, cerebral, and cardiovascular variables, including transpulmonary pressure.

Study Design

Study Type:
Interventional
Actual Enrollment :
27 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Relation Between Lung Protective Mechanical Ventilation, Intracranial Pressure, Autoregulation and Brain Oxygenation in Neurointensive Care Patients
Actual Study Start Date :
Jun 1, 2019
Actual Primary Completion Date :
Sep 1, 2021
Actual Study Completion Date :
Jan 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ventilator setting

Positive end-expiratory pressure , Tidal volume

Procedure: Lung protective ventilator settings
Positive end-expiratory pressure 12, Tidal volume 6 milliliter/kilogram predicted body weight

Outcome Measures

Primary Outcome Measures

  1. Intracranial pressure [120 minutes]

    intracranial pressure increase with lung protective setting

  2. pressure reactivity index [120 minutes]

    Diminished pressure reactivity index

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • • Any tracheally intubated or tracheotomized adult patient with ABI with GCS< 9 on controlled ventilation requiring continuous ICP measurement.

  • Proxy informed consent from relatives.

Exclusion Criteria:
  • • ICP > 22 mmHg before treatment of high ICP

  • Acute respiratory failure defined as partial pressure of oxygen/ inspiratory oxygen fraction (PaO2/FiO2) ratio < 40 kPa and Xray pathology

  • History of pulmonary disese: Chronic respiratory failure diagnosis stage III and IV in the GOLD classification, pulmectomy, lobectomy or restrictive lung disease.

  • Body mass index (BMI) > 35.

  • Known right or biventricular cardiac failure with cardiac index < 2,5 L/min/m2 or ejection fracture < 40 %.

  • Refractory hypovolemia as diagnosed with pulse pressure variation > 12 % with tidal volume 8 ml/predicted bodyweight (intubated on controlled ventilation) or passive leg rise test with > 10 % increase in stroke volume measured by VTI echocardiography or PICCO.

  • Medulla lesion that affect the autonomic nervous system.

  • Patients who has undergone decompressive craniectomy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital North Norway Tromsø Troms Norway 9010

Sponsors and Collaborators

  • University Hospital of North Norway
  • Cambridge University Hospitals NHS Foundation Trust
  • Hôpital de la Croix-Rousse

Investigators

  • Principal Investigator: Shirin K Frisvold, University Hospital of North Norway

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Shirin Kordasti Frisvold, Principal investigator, PhD, University Hospital of North Norway
ClinicalTrials.gov Identifier:
NCT03278769
Other Study ID Numbers:
  • Brain-Vent
First Posted:
Sep 12, 2017
Last Update Posted:
May 23, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 23, 2022